Selvita will present at the 18th Annual BIO CEO & Investor Conference 2016

Krakow, 1 February 2016 – Selvita S.A. (WSE: SLV), the largest drug discovery company in Central and Eastern Europe, today announced that Pawel Przewiezlikowski, Chief Executive Officer of the company, will present at the upcoming 18th Annual BIO CEO & Investor Conference, which will take place on February 8 –…

More

Selvita joins the European network of laboratories EU NETVAL

Krakow, December 15, 2015 – Selvita, the largest drug discovery company in Central and Eastern Europe, announced today that its Cell and Molecular Biology Laboratory has been incorporated into the European network of laboratories EU NETVAL (European Union Network of Laboratories for the Validation of Alternative Methods; https://eurl-ecvam.jrc.ec.europa.eu/eu-netval ).  …

More

Selvita wins the European Rising Star Award

Krakow, Poland – December 10, 2015 – Selvita, the largest drug discovery company in Central and Eastern Europe, was awarded the European Rising Star Award in the prestigious European Small and Mid-Cap Awards competition, organized by the Federation of European Stock Exchanges (FESE) and the European Issuers Association, in collaboration…

More

Merck and Selvita Announce Drug Discovery Collaboration

Focus is to discover small molecule lead candidates for multiple oncology indications   Darmstadt, Germany, Krakow, Poland – November 2, 2015 – Merck, a leading science and technology company, announced today that its healthcare business has entered into a three-year collaboration to validate new therapeutic concepts in the field of…

More

...89101112...